BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 9163605)

  • 1. Further characterization of morphologically defined typical and atypical CLL: a clinical, immunophenotypic, cytogenetic and prognostic study on 390 cases.
    Criel A; Verhoef G; Vlietinck R; Mecucci C; Billiet J; Michaux L; Meeus P; Louwagie A; Van Orshoven A; Van Hoof A; Boogaerts M; Van den Berghe H; De Wolf-Peeters C
    Br J Haematol; 1997 May; 97(2):383-91. PubMed ID: 9163605
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In B-cell chronic lymphocytic leukaemia chromosome 17 abnormalities and not trisomy 12 are the single most important cytogenetic abnormalities for the prognosis: a cytogenetic and immunophenotypic study of 480 unselected newly diagnosed patients.
    Geisler CH; Philip P; Christensen BE; Hou-Jensen K; Pedersen NT; Jensen OM; Thorling K; Andersen E; Birgens HS; Drivsholm A; Ellegaard J; Larsen JK; Plesner T; Brown P; Andersen PK; Hansen MM
    Leuk Res; 1997; 21(11-12):1011-23. PubMed ID: 9444933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trisomy 12 defines a group of CLL with atypical morphology: correlation between cytogenetic, clinical and laboratory features in 544 patients.
    Matutes E; Oscier D; Garcia-Marco J; Ellis J; Copplestone A; Gillingham R; Hamblin T; Lens D; Swansbury GJ; Catovsky D
    Br J Haematol; 1996 Feb; 92(2):382-8. PubMed ID: 8603004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical, immunophenotypic, and molecular profiling of trisomy 12 in chronic lymphocytic leukemia and comparison with other karyotypic subgroups defined by cytogenetic analysis.
    Athanasiadou A; Stamatopoulos K; Tsompanakou A; Gaitatzi M; Kalogiannidis P; Anagnostopoulos A; Fassas A; Tsezou A
    Cancer Genet Cytogenet; 2006 Jul; 168(2):109-19. PubMed ID: 16843100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic analysis of B cell chronic lymphoid leukemias classified according to morphologic and immunophenotypic (FAB) criteria.
    Hernandez JM; Mecucci C; Criel A; Meeus P; Michaux I; Van Hoof A; Verhoef G; Louwagie A; Scheiff JM; Michaux JL
    Leukemia; 1995 Dec; 9(12):2140-6. PubMed ID: 8609731
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic relevance of the FAB morphological criteria in chronic lymphocytic leukemia: correlations with IgVH gene mutational status and other prognostic markers.
    Schwarz J; Mikulenková D; Cermáková M; Polanská V; Michalová K; Marinov I; Campr V; Ransdorfová S; Marková J; Pavlistová L; Brezinová J; Sajdová J; Sponerová D; Volková Z; Benesová K; Cermák J; Vítek A; Cetkovský P
    Neoplasma; 2006; 53(3):219-25. PubMed ID: 16652191
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The concept of typical and atypical chronic lymphocytic leukaemia.
    Criel A; Michaux L; De Wolf-Peeters C
    Leuk Lymphoma; 1999 Mar; 33(1-2):33-45. PubMed ID: 10194119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluorescence in situ hybridization detection of cytogenetic abnormalities in B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma.
    Aoun P; Blair HE; Smith LM; Dave BJ; Lynch J; Weisenburger DD; Pavletic SZ; Sanger WG
    Leuk Lymphoma; 2004 Aug; 45(8):1595-603. PubMed ID: 15370211
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Prognostic factors for chronic lymphocytic leukemia with typical and atypical immunophenotype].
    Cao X; Xu W; Wu YJ; Qiao C; Liu Q; Fan L; Miao KR; Li JY
    Zhonghua Xue Ye Xue Za Zhi; 2009 Jul; 30(7):450-3. PubMed ID: 19954596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular basis of aggressive disease in chronic lymphocytic leukemia patients with 11q deletion and trisomy 12 chromosomal abnormalities.
    Mittal AK; Hegde GV; Aoun P; Bociek RG; Dave BJ; Joshi AD; Sanger WG; Weisenburger DD; Joshi SS
    Int J Mol Med; 2007 Oct; 20(4):461-9. PubMed ID: 17786276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atypical chronic lymphocytic leukaemia with t(11;14)(q13;q32): karyotype evolution and prolymphocytic transformation.
    Cuneo A; Balboni M; Piva N; Rigolin GM; Roberti MG; Mejak C; Moretti S; Bigoni R; Balsamo R; Cavazzini P
    Br J Haematol; 1995 Jun; 90(2):409-16. PubMed ID: 7794764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cytogenetic and molecular abnormalities in chronic lymphocytic leukaemia.
    Oscier DG
    Blood Rev; 1994 Jun; 8(2):88-97. PubMed ID: 7950479
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Karyotype correlates with peripheral blood morphology and immunophenotype in chronic lymphocytic leukemia.
    Finn WG; Thangavelu M; Yelavarthi KK; Goolsby CL; Tallman MS; Traynor A; Peterson LC
    Am J Clin Pathol; 1996 Apr; 105(4):458-67. PubMed ID: 8604688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of trisomy 12, del(13q), del(17p), and del(11q) on the immunophenotype, DNA ploidy status, and proliferative rate of leukemic B-cells in chronic lymphocytic leukemia.
    Quijano S; López A; Rasillo A; Sayagués JM; Barrena S; Sánchez ML; Teodosio C; Giraldo P; Giralt M; Pérez MC; Romero M; Perdiguer L; Orfao A
    Cytometry B Clin Cytom; 2008 May; 74(3):139-49. PubMed ID: 18061951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia.
    Chevallier P; Penther D; Avet-Loiseau H; Robillard N; Ifrah N; Mahé B; Hamidou M; Maisonneuve H; Moreau P; Jardel H; Harousseau JL; Bataille R; Garand R
    Br J Haematol; 2002 Jan; 116(1):142-50. PubMed ID: 11841407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The influence of different chromosomal aberrations on molecular cytogenetic parameters in chronic lymphocytic leukemia.
    Amiel A; Leopold L; Gronich N; Yukla M; Fejgin MD; Lishner M
    Cancer Genet Cytogenet; 2006 Jun; 167(2):145-9. PubMed ID: 16737914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Total body computed tomography scan in the initial work-up of Binet stage A chronic lymphocytic leukemia patients: Results of the prospective, multicenter O-CLL1-GISL study.
    Gentile M; Cutrona G; Fabris S; Pesce EA; Baldini L; Di Raimondo F; Musolino C; Di Tonno P; Di Renzo N; Molica S; Brugiatelli M; Ilariucci F; Zupo S; Matis S; Maura F; Vigna E; Angrilli F; Recchia AG; Quarta G; Iannitto E; Fragasso A; Musto P; Spriano M; Vincelli I; Vallisa D; Cortelezzi A; Mauro FR; Foà R; Federico M; Neri A; Ferrarini M; Morabito F
    Am J Hematol; 2013 Jul; 88(7):539-44. PubMed ID: 23553682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
    Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
    Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node histology in typical and atypical chronic lymphocytic leukemia.
    Bonato M; Pittaluga S; Tierens A; Criel A; Verhoef G; Wlodarska I; Vanutysel L; Michaux L; Vandekerckhove P; Van den Berghe H; De Wolf-Peeters C
    Am J Surg Pathol; 1998 Jan; 22(1):49-56. PubMed ID: 9422315
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Morphological and immunophenotypic features of chronic lymphocytic leukemia.
    Matutes E; Polliack A
    Rev Clin Exp Hematol; 2000 Mar; 4(1):22-47. PubMed ID: 11486329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.